The antimicrobial peptide cathelicidin-BF could be a potential therapeutic for Salmonella typhimurium infection
Authors:
- 1 February 2015
- journal article
- Published by Elsevier in Microbiological Research
- Vol. 171, 45-51
Abstract
No abstract availableKeywords
Funding Information
- National Science Foundation (31025027)
- Earmarked Fund for Modern Agro-industry Technology Research System
This publication has 29 references indexed in Scilit:
- Immunity to salmonellosisImmunological Reviews, 2011
- The proline-rich peptide Bac7(1-35) reduces mortality from Salmonella typhimurium in a mouse model of infectionBMC Microbiology, 2010
- Shiga Toxin-Mediated Disease in MyD88-Deficient Mice Infected with Escherichia coli O157:H7The American Journal of Pathology, 2008
- Epidemics of InvasiveSalmonella entericaSerovar Enteritidis andS. entericaSerovar Typhimurium Infection Associated with Multidrug Resistance among Adults and Children in MalawiClinical Infectious Diseases, 2008
- Cationic antimicrobial peptides: update of clinical developmentJournal of Internal Medicine, 2004
- Role of the cystic fibrosis transmembrane conductance regulator in internalization of Pseudomonas aeruginosa by polarized respiratory epithelial cellsCellular Microbiology, 2004
- Pretreatment of Mice with Streptomycin Provides aSalmonella entericaSerovar Typhimurium Colitis Model That Allows Analysis of Both Pathogen and HostInfection and Immunity, 2003
- Microbial pathogenesis and cytoskeletal functionNature, 2003
- Cathelicidins - a family of multifunctional antimicrobial peptidesCellular and Molecular Life Sciences, 2003
- Type III Secretion Machines: Bacterial Devices for Protein Delivery into Host CellsScience, 1999